We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App




Diagnostic Assay and Handheld Analyzers Exhibited in Dubai

By LabMedica International staff writers
Posted on 28 Jan 2015
A global diagnostics company exhibited its new early sepsis assay and point-of-care hemoglobin analyzer, and previewed its new lactate analyzer at Arab Health 2015.

EKF Diagnostics (Cardiff, UK) exhibited at Arab Health 2015 (January 26-29, Dubai, UAE) to highlight its new DiaSpect Tm handheld hemoglobin analyzer and new CE-marked Liquicolor Procalcitonin liquid-stable assay for early sepsis detection. More...
EKF also previewed SensPoint, a new handheld lactate analyzer with built-in connectivity functions to hospital or laboratory information systems.

DiaSpect Tm is a robust, heat and humidity compatible analyzer delivering immediate hemoglobin results at point-of-care (POC). The lightweight, palm-sized analyzer is reliable for anemia diagnosis in almost all climatic conditions. DiaSpect Tm combines laboratory-quality performance with unmatched measurement speed. Its extensive battery life of 40 days of continuous use, or 10,000 tests, enables long-term use outside of laboratories and in remote resource-poor locations.

DiaSpect Tm is proving highly effective in challenging POC testing (POCT) conditions in many locations, including east Africa and south-east Asia, where heat and humidity can affect performance of devices and blood collection cuvettes. DiaSpect Tm is unaffected by these environmental factors due to its reagent-free disposable cuvettes, and the fact that it has no moving parts.

The plexiglass micro-cuvettes used by DiaSpect Tm have a shelf life of 2.5 years when stored between 0–50 °C, so refrigeration is not necessary. Short-term storage is possible at -3–70 °C for a maximum of 24 hours. Also making it ideal for POCT is that DiaSpect Tm is factory calibrated against the HiCN reference method in accordance with ICSH and requires no recalibration or maintenance, as it undertakes an automatic self-check between every measurement.

DiaSpect Tm is easy to use and requires minimal training as the user simply collects a capillary or venous blood sample of <10 µL into the microcuvette and inserts it directly into the analyzer. Hemoglobin results are delivered in 1 second, and can be downloaded to a computer (via USB or Bluetooth).

The new CE-marked Liquicolor Procalcitonin liquid-stable immunoturbidimetric assay provides early and specific indication of sepsis and can be used on most automatic chemistry analyzers. Since Procalcitonin (PCT) levels elevate during systemic bacterial infection and sepsis, a PCT test can quickly assess initial sepsis severity. Liquicolor PCT is precise, convenient, and cost effective. It can remain stable on-board the analyzer for up to 4 weeks, and requires a minimal sample of just 20 µL. This assay can be run on a primary chemistry analyzer and eliminate the need for sample splitting, thus improving laboratory workflow.

Liquicolor Procalcitonin assay is currently unavailable for sale in USA, France, Germany, Austria, Spain, Italy, and Japan.

Related Links:

EKF Diagnostics



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Pipette Calibration System
Artel PCS®
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.